One of the most prevalent issues in the industry today, many pharma businesses are talking about serialization. However, a recent survey has found that 42% of contract manufacturing organisations (CMOs) are not prepared for the changes that the new legislation will bring.

In addition to other industry leaders, Dexter Tjoa, Director Corporate Strategy, has spoken to Contract Pharma about how companies will need to change in order to meet the demands of serialization.

You can read the full article here.

One of the most prevalent issues in the industry today, many pharma businesses are talking about serialization. However, a recent survey has found that 42% of contract manufacturing organisations (CMOs) are not prepared for the changes that the new legislation will bring.

In addition to other industry leaders, Dexter Tjoa, Director Corporate Strategy, has spoken to Contract Pharma about how companies will need to change in order to meet the demands of serialization.

You can read the full article here.

To continue reeading fill in the form below:

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Ready to shape the future of your pharmaceutical supply chain?